Collectively, our data and the existing literature suggest that in the context of brain neoplasm like GB, the transcriptional regulator ID2 can contribute positively to tumour progression, exerting effects on the malignant cells themselves, as well as myeloid cells, such as microglia within their tumour microenvironment. This evidence concerns the gene ID2 and brain cancer.